Alzheimers disease is the most common cause of neurodegeneration in the elderly.Since cholinergic deficit and excitatory amino acid toxicity are the well recognized pathologies in the Alzheimers brain,the correlated clinical drug treatments mainly include cholinesterase inhibitors and N-methyl-D-aspartate receptor(NMDAR)antagonist.